HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 89 filers reported holding HARVARD BIOSCIENCE INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $628,000 | -24.2% | 90,020 | -9.5% | 0.76% | -21.1% |
| Q2 2021 | $828,000 | +12.3% | 99,420 | -26.4% | 0.97% | +11.1% |
| Q1 2021 | $737,000 | +35.5% | 135,031 | +6.6% | 0.87% | +17.1% |
| Q4 2020 | $544,000 | -5.1% | 126,694 | -33.5% | 0.74% | -6.8% |
| Q3 2020 | $573,000 | -3.0% | 190,494 | 0.0% | 0.80% | +2.8% |
| Q2 2020 | $591,000 | +111.8% | 190,494 | +50.9% | 0.78% | +99.5% |
| Q1 2020 | $279,000 | -30.2% | 126,242 | -3.7% | 0.39% | +12.1% |
| Q4 2019 | $400,000 | -0.7% | 131,042 | 0.0% | 0.35% | -1.4% |
| Q3 2019 | $403,000 | -45.2% | 131,042 | -64.3% | 0.35% | -33.2% |
| Q2 2019 | $735,000 | -60.8% | 367,442 | -15.5% | 0.53% | -54.9% |
| Q1 2019 | $1,875,000 | +6.7% | 435,007 | -21.3% | 1.17% | +6.3% |
| Q4 2018 | $1,758,000 | -31.6% | 552,923 | +13.0% | 1.10% | +14.2% |
| Q3 2018 | $2,569,000 | +12.4% | 489,320 | +14.5% | 0.96% | +8.0% |
| Q2 2018 | $2,285,000 | +37.5% | 427,172 | +28.5% | 0.89% | +33.8% |
| Q1 2018 | $1,662,000 | – | 332,492 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Engine Capital Management, LP | 3,542,852 | $10,536,000 | 4.92% |
| Fondren Management LP | 865,000 | $2,660,000 | 2.21% |
| Harvey Partners, LLC | 742,500 | $2,283,000 | 1.65% |
| BARD ASSOCIATES INC | 311,922 | $959,000 | 0.49% |
| Adirondack Research & Management Inc. | 131,042 | $403,000 | 0.35% |
| Granahan Investment Management | 1,771,964 | $5,449,000 | 0.30% |
| DALTON GREINER HARTMAN MAHER & CO | 1,373,518 | $4,224,000 | 0.29% |
| HEARTLAND ADVISORS INC | 1,000,000 | $3,075,000 | 0.24% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 499,616 | $1,536,000 | 0.22% |
| Alambic Investment Management, L.P. | 43,569 | $134,000 | 0.10% |